...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
Reply New Message
Back To Forum List View
Icon president Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
4
BearDownAZ
Aug 06, 2019 08:37AM
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
4
noretreat
Aug 06, 2019 09:11AM
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
4
RVXoldtimer
Aug 06, 2019 10:49AM
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
4
Nextblockbuster
Aug 06, 2019 11:32AM
Icon president Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
9
BearDownAZ
Aug 06, 2019 12:39PM
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
5
RVXoldtimer
Aug 06, 2019 01:20PM

In my view there never was going to be any kind of Zenith sale until after BetOnMace trial completion.  I'm actually kind of surprised this announcement didn't wait as well.

3 Recommendations
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
4
Toinv
Aug 07, 2019 11:20AM
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
5
RVXoldtimer
Aug 08, 2019 03:20PM
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
4
Toinv
Aug 08, 2019 03:21PM
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
6
Toinv
Aug 09, 2019 01:37PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply